“Mobile health gives us the critical ability to communicate to these patients in real-time and answer their questions.”

WASHINGTON (PRWEB)
March 09, 2020

Fears surrounding the spread of Novel Coronavirus 2019 (COVID-19) have sparked increased engagement with digital health in pregnant women looking for the latest updates on the virus. Babyscripts, the leading virtual care company for managing obstetrics, teamed up with clinical partner George Washington Medical Faculty Associates (GW-MFA) to disseminate relevant information about COVID-19 to new and expecting mothers. Mothers have engaged with the education at a rate of 98%, a stat that confirms how much mothers value real-time updates from their trusted provider.

Medical and product teams at Babyscripts and GW-MFA compiled a new resource complete with clear and concise recommendations and references to provide information on the virus and guidance on how to prevent its spread, and uploaded it to the mobile app for immediate patient access. The COVID-19 custom campaign from GW-MFA and Babyscripts limits the opportunity for disinformation, giving patients access to secure and accurate information directly from their trusted care provider in real-time. With new outbreaks and fresh information around the virus presenting every day, a dynamic and secure vehicle for communicating new advisories immediately to pregnant patients has proven essential.

“When I saw the email notification with the FAQs come through on the virus, I was relieved because until I received the notification through Babyscripts, I didn’t know whether I should be concerned,” said Miki Smith, a pregnant patient at GW-MFA who is in her second trimester. “There is a lot of misinformation out there. Given the evolving situation, it was helpful to get a consolidated position from my medical group: here is what to do and here is the actual risk. I could have gone to the CDC website and searched, but it felt better to get something from the medical team that I’m already getting care from.”

Babyscripts will mount similar campaigns for all of their health system partners surrounding the Coronavirus to ensure that all patients have access to timely and relevant information around current advisories and staying healthy while pregnant. Working with their medical community, Babyscripts has drafted a general resource to be launched in the Babyscripts app that will be customizable by practice. The resource can be modified at any time by the provider, to ensure that patients are receiving the most up-to-date information.

“At times of crisis like this, access to accurate information is key for reducing anxiety and panic,” said Juan Pablo Segura, President and Co-founder of Babyscripts. “There’s a lot of conflicting information floating around on the internet, and pregnant women are especially vulnerable because they’re in a unique situation that complicates their normal responses to things like virus-protection. Mobile health gives us the critical ability to communicate to these patients in real-time and answer their questions.”

Babyscripts provides a virtual care solution for obstetrics that allows healthcare providers to deliver a new model of prenatal and postpartum care. Through a mobile app and remote monitoring experiences, the Babyscripts solution enables earlier risk detection and intervention, driving improved outcomes and increasing patient engagement and satisfaction. With Babyscripts’ seamless integration, providers can automate certain aspects of care to streamline workflow, improve patient outcomes, and increase practice reimbursement.

About Babyscripts

Babyscripts is a company delivering a new model for prenatal and postpartum care that is transforming the way expectant mothers use technology to work with their healthcare providers. We’ve spent the last six years delivering the most-implemented mobile clinical solution for remote monitoring in pregnancy, with the mission to eliminate maternal mortality and improve access to care for all mothers. For more information on our virtual care solution and to request a demo, visit http://www.babyscripts.com.

Share article on social media or email:

To have the opportunity to collaborate with a visionary team that pushes the limit on what can be done to improve a patient’s overall healthcare experience is exciting!

BIRMINGHAM, Ala. (PRWEB)
March 10, 2020

PharmaPoint is proud to announce that Dave Wojczynski, president of TransUnion Healthcare, has been added as the newest member of its board. Wojczynski brings more than two decades of industry experience to the leadership team.

“As we continue to grow and diversify, the input of experienced leaders is priceless,” says Mike Plaia, PharmaPoint Chairman and CEO. “I have known and worked with Dave for years. His ability to speak candidly and make decisions in a timely manner are just two of his attributes I most admire. Those, coupled with his unwavering commitment to excellence, make him a perfect addition to our leadership team.”

Before serving in his current role, Wojczynski served as senior vice president and Chief Operating Officer (COO) of TransUnion Healthcare, in which he was responsible for leading the operations and service delivery teams. Prior to joining TransUnion, Wojczynski served as COO for DAXKO, a member-based health and wellness industry software and payments provider.

“I am honored to serve as a board member for PharmaPoint,” says Wojczynski. “This company is doing significant things to disrupt the ever-changing landscape of healthcare. To have the opportunity to collaborate with a visionary team that pushes the limit on what can be done to improve a patient’s overall healthcare experience is exciting!”

Wojczynski has also held senior positions at Emageon, a diagnostic imaging software business, SourceMed, the leading provider of ambulatory surgery center software solutions, and General Electric. He received his Bachelor of Science degree at the United States Military Academy at West Point and his Master of Business Administration degree from Northwestern University’s Kellogg School of Management. Wojczynski also serves on the board for VisitPay, an online patient financial engagement platform company.

About PharmaPoint

PharmaPoint is an innovative, technology-enabled pharmacy management and software company. Through the management of outpatient retail pharmacies for hospitals, health systems and physician groups, our commitment to completing the care continuum results in improved patient health and satisfaction, reduced healthcare costs, and provides clients with a source of ancillary income. Additionally, XchangePoint, our proprietary integrated workflow management system supporting medication management across care transitions, is designed for pharmacy and care team members to drive medication optimization for at-risk patients in the acute, post-acute and ambulatory care settings. PharmaPoint has been recognized as one of the most innovative, inspiring and fastest growing private companies for six consecutive years (2013-2018) by Inc. Magazine. Headquartered in Birmingham, Ala., we are currently managing pharmacies across the United States. For more information about our company, please visit http://www.pharmapoint.com.

About TransUnion (NYSE: TRU)

TransUnion is a global information and insights company that makes trust possible in the modern economy. We do this by providing a comprehensive picture of each person so they can be reliably and safely represented in the marketplace. As a result, businesses and consumers can transact with confidence and achieve great things. We call this Information for Good®. TransUnion Healthcare, a wholly owned subsidiary of TransUnion, makes mutual trust possible between patients, providers, and payers by helping them navigate payment uncertainty. Our Revenue Protection® solutions leverage comprehensive data, accurate insights and industry expertise to engage patients early, ensure earned revenue gets paid and optimize payment strategies. TransUnion Healthcare helps over 1,850 hospitals and 550,000 physicians collectively recover more than $1.2 billion annually in revenue. A leading presence in more than 30 countries across five continents, TransUnion provides solutions that help create economic opportunity, great experiences and personal empowerment for hundreds of millions of people. http://www.transunionhealthcare.com

Share article on social media or email:

This is a major breakthrough from ScreenPoint Medical and it means that our new and existing US customers now have access to the power of Transpara 3D for the first time

MIDDLETON, Wis. (PRWEB)
March 09, 2020

U.S. FDA clears Transpara 1.6.0 manufactured by ScreenPoint Medical, the first breast AI solution for both 2D and 3D mammography in the USA.

In order to obtain FDA clearance, the company performed a clinical reader study which demonstrated that accuracy of radiologists significantly improved when reading 3D mammograms with support from Transpara. In addition, 3D reading time was significantly reduced to about 35 seconds per exam, bringing it close to 2D reading efficiency.

“We are delighted that the U.S. FDA has cleared Transpara 1.6.0 to be marketed in the USA. This is a major breakthrough from ScreenPoint Medical and it means that our new and existing US customers now have access to the power of Transpara 3D for the first time,” says CEO Nico Karssemeijer. “Multiple independent peer reviewed publications have already demonstrated that Transpara significantly improves accuracy in 2D mammography, now the same applies for 3D.”

“We also understand that reading 3D mammography presents radiologists with huge workload challenges. With feedback from the field, we redesigned the Transpara 1.6.0 interface and utilised our patented co-registration slice technology to optimise reading workflow with advanced navigation support to significantly reduce reading times.”

Pieter Kroese, COO at ScreenPoint Medical adds, “Transpara 1.6.0 heralds a new era in breast AI in terms of 2D and 3D workflow. Transpara is the leading evidence-based breast AI solution for mammography, with clinical installations in over 15 countries and over 500,000 mammograms processed so far by our clinical users. This is a significant achievement and demonstrates the strong trust that we share with our clinical partners and that Transpara breast AI is making a difference for women and the detection, diagnosis and treatment of breast cancer.”

Transpara 1.6.0 is marketed in North America by ScreenPoint Medical Inc, Siemens Healthineers USA and Volpara Solutions.

About ScreenPoint Medical BV.

ScreenPoint Medical is the leading developer of AI driven image analysis technology which enables the automated reading of mammograms and digital breast tomosynthesis examinations. With proven accuracy at least matching that of experienced radiologists, ScreenPoint’s Transpara™ system is the most advanced available, exploiting Big Data, Deep Learning and the latest advances in Artificial Intelligence. The system can identify high risk breast lesions quickly, enabling earlier detection, earlier treatment and a greater chance of survival.

ScreenPoint Medical was founded in 2014 by Professor Nico Karssemeijer and Professor Sir Michael Brady, two internationally respected experts in breast imaging, machine learning and computer aided detection.

The company’s Head Office is in Nijmegen, The Netherlands.

For more information, please email info@screenpointmed.com

Share article on social media or email:

We like to say that, ‘The time to deploy texting is well before it is needed.’ With the coronavirus likely to continue spreading for some time, bringing with it even more panic, the time to deploy texting is as soon as possible.

FRANKLIN, Tenn. (PRWEB)
March 09, 2020

As the coronavirus continues to spread nationwide, Dialog Health is advising healthcare facilities to place a priority on delivering effective messaging concerning infection prevention and protocols.

“The coronavirus represents a significant unknown that is impacting people and processes in ways that known entities like the flu do not,” said Brandon Daniell, president and co-founder of Dialog Health, a two-way texting platform that enables information to be pushed to and pulled from patients, caregivers and healthcare facility staff. “There is a growing sense of panic that this unknown is now fueling. While the panic is not all justified, it cannot be ignored.”

Healthcare facilities have a responsibility to keep patients, staff, providers and vendors safe. “At a time like this, timely communication and appropriate messaging are even more critical,” Daniell said.

Here are examples of messages healthcare facilities should consider sharing with the people coming to their buildings.

• 
  For patients and vendors: “If you are not feeling well or are taking care of someone who is ill, please contact us to reschedule your appointment.”
• For staff: “If you are not feeling well or are taking care of someone who is ill, please call the office to reschedule your shift.”
• For anyone: “Please be advised that we have implemented a NO handshake policy on the premise at all times.”
• For staff and providers: “As a valued team member, please remember the importance of following hand hygiene, masking and all other hygiene-related policies per your training.”
• For patients, family members and vendors: “While in our waiting room or other areas of the facility, please cover your nose and mouth if you sneeze and cough. We have tissues and hand sanitizer located throughout the waiting room for your use. Please use both!”
• For everyone: “To reduce your risk of spreading infection, remember to wash your hands frequently with soap and warm water for at least 20 seconds. It helps to sing ‘Happy Birthday’ twice. Also, keep your hands away from your eyes, nose and mouth.”
• For staff: “Remember that we have changed our patient pre-screening and screening upon admission policies to include asking where patients have traveled. If you have any concerns about admitting a patient, please speak with your supervisor.”

Spreading the Word, Not the Virus

It is essential to establish processes to best ensure these and other timely messages are distributed in an efficient and effective manner. Posting notices on facility websites, social media and around the building itself are worthwhile. Outbound communication like phone calls and emails can work as well. But texting is likely your best option for mass communication.

“Text messaging is a proven method for quickly reaching and successfully engaging with patients, staff, providers and vendors,” Daniell says. “If you need to get a message out fast, to a significant number of people and with a high degree of confidence that your audience will receive and read it, send that message as a text.”

Daniell continues, “We like to say that, ‘The time to deploy texting is well before it is needed.’ With the coronavirus likely to continue spreading for some time, bringing with it even more panic, the time to deploy texting is as soon as possible.”

Interview Requests

Members of the media interested in speaking with Brandon Daniell about text messaging, emergency preparedness and mass communication should email info@dialoghealth.com or call (877) 666-1132 if on a deadline.

About Dialog Health

Dialog Health Inc. is a U.S.-based company that provides a two-way texting platform to organizations which they can leverage as a communication and engagement channel. Two-way texting is a convenient, fast, effective and affordable communication resource for stakeholder engagement. For more information, visit http://www.dialoghealth.com, call (877) 666-1132 and follow Dialog Health on LinkedIn.

Share article on social media or email:

“With the addition of Pharmaworks, ProMach can now meet nearly any pharmaceutical customer’s packaging needs – whether it’s in rigid bottles or flexible blister packs – and help them grow their business with a proven partner.” – Michel Lapierre, ProMach, President, Pharma Business Line

CINCINNATI (PRWEB)
March 09, 2020

ProMach, a worldwide leader in packaging machinery solutions, announced today it has acquired Pharmaworks, a leading provider of blister packaging technology for the pharmaceutical, consumer goods, and contract packaging industries. The addition of Florida-based Pharmaworks significantly expands ProMach’s portfolio of pharmaceutical solutions and strengthens its integrated solutions capabilities for a broad range of applications.

Pharmaworks, founded in 2001, offers a robust and flexible lineup of themoforming solutions for the creation of blister packs, a packaging format commonly used in over-the-counter (OTC) and prescription unit dose pharmaceutical and consumer goods packaging. Pharmaworks blister packaging solutions range from semi-automated thermoformers to fully automated systems capable of speeds up to 600 packages per minute. In addition to their core blister packaging machinery, Pharmaworks also provides feeding, transferring, collating, cartoning, and vision/inspection systems, as well as a comprehensive aftermarket support program with parts, service, machinery rebuilds/upgrades, controls upgrades, tooling, accessories, and much more. Additionally, Pharmaworks provides complete blister line integration services for customers needing turnkey blister packaging lines, complete with validation documentation.

“We’re pleased to welcome the Pharmaworks team to ProMach,” said Mark Anderson, ProMach President and CEO. “The pharmaceutical industry has been a strong growth engine for ProMach over the last five years, beginning with our acquisition of NJM in 2016 and continuing with the addition of WLS in 2017 and now Pharmaworks in 2020. The research forecasts continued strong growth in the pharmaceutical sector over the next few years, and blister packs are a key part of that growth story driven by consumer convenience and safety, particularly with regulations around serialization. I am excited to work with the outstanding senior leadership team at Pharmaworks as they continue developing new innovative solutions, expanding into new markets, and growing their already successful business to even greater heights.”

Odessa, Florida-based Pharmaworks and its over 100 employees are joining the ProMach team. Current Pharmaworks President, Peter Buczynsky, will join ProMach as Vice President and General Manager of Pharmaworks. He will be joined by Ingo Federle, Vice President of Technical Operations, and Ben Brower, Vice President of Sales & Marketing.

“ProMach is well regarded in the packaging machinery marketplace for many of the same things that have made Pharmaworks successful – quality, reliability, flexibility, innovation, and integrity,” said Mr. Buczynsky. “Our passion to engineer solutions for pharmaceutical packaging remains at the heart of our business and this deal lets us continue to expand our products, accelerate our pace of innovation, expand our manufacturing operations, more quickly add talented team members, and most importantly create additional value for Pharmaworks customers across the globe. We are looking forward to working with the entire ProMach team to continue this journey we embarked on nearly two decades ago.”

“Many of our customers want a full range of pharmaceutical packaging options from a single source,” said Michel Lapierre, President of ProMach’s Pharma Business Line. “With the addition of Pharmaworks, ProMach can now meet nearly any customer’s needs – whether it’s in rigid bottles or flexible blister packs, from solid dose tablets, capsules, and lozenges to liquid vials, ampoules, and pre-filled syringes – and help them grow their business with a proven partner.”

For more information about Pharmaworks please call +1 (727) 232-8200 or visit them online at http://www.Pharmaworks.com.

About ProMach

ProMach is a family of best-in-class packaging solution brands serving manufacturers of all sizes and geographies in the food, beverage, pharmaceutical, personal care, and household and industrial goods industries. ProMach brands operate across the entire packaging spectrum: filling and capping, flexibles, pharma, product handling, labeling and coding, and end of line. ProMach also provides complete turnkey packaging lines, including engineering services, integration, and software to optimize packaging line design and deliver maximum uptime.

ProMach designs, manufactures, integrates, and supports the most sophisticated and advanced packaging solutions in the global marketplace. Its diverse customer base, from Fortune 500 companies to smaller, privately-held businesses worldwide, depends on reliable, flexible, technologically advanced equipment and integrated solutions. ProMach is headquartered near Cincinnati, Ohio, with manufacturing facilities and offices throughout North America, Europe, South America, and Asia. For more information about ProMach, visit http://www.ProMachBuilt.com.

Share article on social media or email:

Pinnacle Customer Experience Award

LOS ANGELES (PRWEB)
March 09, 2020

Windsor Convalescent Center of North Long Beach, California and Encanto Palms Assisted Living in Phoenix, Arizona announced today that they are the recipients of Pinnacle Quality Insight’s 2020 Customer Experience AwardTM.

Pinnacle Quality Insight conducts thousands of monthly phone surveys to establish a comprehensive review of their clients and gauge resident satisfaction. Every year, Pinnacle awards clients who have excelled at providing a superior customer experience for their patients and residents. Out of 2,700 care providers and 150,000 customer interviews conducted each year, only those scoring in the top 15% across a 12-month average receive the award.

Clients who achieve a Customer Experience Award must score well in at least one of the following categories: Overall, satisfaction, Nursing Care, Dining Service, Quality of Food, Cleanliness, Individual Needs, Laundry Service, Communication from Facility, Response to Problems, Treatment/Dignity, Recommend Facility to Others, Recreational Activities, Professional Therapy Services, Admission Process, Overall Safety, Overall Customer Experience

“Throughout its history, Windsor has always placed a strong emphasis on ensuring that the individual needs of every resident are met,” says Mike Hurtado, Administrator at Windsor Convalescent Center of North Long Beach. “Over the course of 2019, a sampling of our residents and their families participated in monthly telephone interviews, and we are thrilled to be receive Pinnacle’s 2020 Customer Experience Award.”

“I feel privileged to serve with such amazing leaders as those at Encanto Palms Assisted Living,” adds Dr. Charles Villafranca, DHA(ABD), MSHA/HM, Administrator and Executive Director at Encanto Palms Assisted Living.

About Pinnacle Quality Insight

A customer satisfaction measurement firm with 24 years of experience in post-acute healthcare, Pinnacle conducts over 150,000 phone surveys each year and works with more than 2,500 care providers in all 50 US states, Canada and Puerto Rico.

About Windsor

Windsor Convalescent Center of North Long Beach and Encanto Palms Assisted Living are associated with Windsor healthcare centers. Windsor provides short-term and long-term healthcare, rehabilitation services and assisted living communities throughout California and Arizona. Windsor employs professionals that provide nursing, therapeutic, sub-acute and rehabilitation care to over 4,000 patients daily.

Share article on social media or email:

“The update to our platform not only conforms to the new standard but represents our continued dedication to being the best quality management system for medical device companies.”

INDIANAPOLIS (PRWEB)
March 09, 2020

Greenlight Guru, the only medical device quality management system (MDQMS), today announced new software platform updates in order to align with the recently updated International Organization for Standardization (ISO) 14971:2019 standard, as well as further enhancements to the Change Management capabilities they debuted in December 2019.

ISO 14971 is the predominant standard for risk management in the medical device industry, of which compliance is required in the United States, Canada, and the European Union. Put into effect in December 2019, ISO 14971:2019 is the latest update to the application of risk management for medical devices. It serves to define better key terminology, residual risk identification, and personnel competence.

“This iteration of the ISO 14971 standard is the first update in nearly 13 years, and offers much-needed clarifications to reflect current best practices,” said Jon Speer, founder and VP of QA/RA at Greenlight Guru. “The update to our platform not only conforms to the new standard but represents our continued dedication to being the best quality management system for medical device companies.”

Greenlight Guru’s timely platform update to help medical device companies comply with these changing regulatory standards is proof that they eliminate the burden of allocating internal resources to update the design and quality processes for customers, allowing them to stay current with evolving industry regulations and compliance requirements.

Updates to the Greenlight Guru platform reflects changes to align with ISO 14971:2019, as well as several productivity enhancements, including:

• 
  Enhanced Change Management capabilities intended to assure medical device companies are systematically assessing the impact of changes through built-in change evaluation functionality
• The debut of Group Management, which gives companies the flexibility to create & manage different Groups of employees based on how their teams or organization are uniquely structured

This announcement comes on the heels of significant enhancements to Greenlight Guru’s Change Management workflows, the launch of Digital Design Reviews, and the company’s fifth consecutive quarter as a G2 Crowd market leader in the quality management software category.

For more information about Greenlight Guru’s Risk Management capabilities, please visit https://www.greenlight.guru/risk-management-software.

About Greenlight Guru

Greenlight Guru is the only quality management software platform designed specifically for medical device companies. The platform helps companies bring safer products to market faster, simplifies FDA and ISO regulatory compliance and provides a single source of truth by connecting the management of all quality processes like CAPAs, risk, audits and more. Greenlight Guru’s platform is used by thousands of users across the globe to push beyond baseline compliance and achieve True Quality for their medical devices. For more information, visit http://www.greenlight.guru.

Media Contact

Kate Johnson

kate_johnson@BLASTmedia.com

(317) 806-1900

Share article on social media or email: